Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site Sort ascending
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Site Sort ascending Location Division Business Functional Area Date Posted
Lead Developer, Generative AI Navigator (GAIN) Platform Hyderabad (Office) India Operations CTS Technology Transformation Oct 07, 2024
Content & Education Specialist Hyderabad (Office) India Operations CTS Marketing Oct 07, 2024
Associate Manager- RIM Hyderabad (Office) India Development Innovative Medicines Research & Development Oct 08, 2024
Manager - Data Quality Hyderabad (Office) India Operations Innovative Medicines Technical Operations Oct 08, 2024
Senior Expert Data Science Hyderabad (Office) India Biomedical Research Pharma Research Data and Digital Oct 08, 2024
Expert Data Science Hyderabad (Office) India Biomedical Research Pharma Research Data and Digital Oct 08, 2024
Specialist-Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Oct 08, 2024
LDC Core Enablement Business and IT Controls Hyderabad (Office) India Operations CTS Audit & Finance Oct 09, 2024
Head DDIT IES Infrastructure Solutions Hyderabad (Office) India Operations CTS Technology Transformation Oct 01, 2024
Business Data Migration Expert – Procurement Hyderabad (Office) India Operations CTS BD&L & Strategic Planning Oct 02, 2024
Specialist-Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Oct 03, 2024
Senior Principal Biostatistician Hyderabad (Office) India Development Innovative Medicines Research & Development Oct 03, 2024
Associate Director of Forensics Hyderabad (Office) India Operations CTS Technology Transformation Oct 10, 2024
Director, Marketing & Digital Data Solution Hyderabad (Office) India Operations CTS Marketing Oct 10, 2024
Director Data Stratagy Hyderabad (Office) India Operations CTS Marketing Oct 10, 2024
Sr. Spec. DDIT IES Projects Hyderabad (Office) India Operations CTS Technology Transformation Oct 10, 2024
Medical Safety Lead Hyderabad (Office) India Development Innovative Medicines Research & Development Oct 10, 2024
Sr. Spec. DDIT IES Projects Hyderabad (Office) India Operations CTS Technology Transformation Oct 10, 2024
Analyst – Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Oct 10, 2024
Senior Financial Analyst- BPA Hyderabad (Office) India Finance CTS Audit & Finance Oct 10, 2024
Senior Analyst, Product Management Hyderabad (Office) India Operations CTS Marketing Oct 10, 2024
Technology Product Manager Hyderabad (Office) India Development Innovative Medicines Research & Development Oct 11, 2024
Senior Financial Analyst - Digital Finance Hyderabad (Office) India Finance Corporate Audit & Finance Oct 16, 2024
Manager - FC&C Hyderabad (Office) India Finance CTS Audit & Finance Oct 16, 2024
Sr. Spec. DDIT IES NW Engg Hyderabad (Office) India Operations CTS Technology Transformation Oct 16, 2024
Senior Analyst Commercial Analytics Hyderabad (Office) India Operations CTS Marketing Oct 16, 2024
Director - LDC Business and IT Controls(SAP S/4 Hana) Hyderabad (Office) India Operations CTS Technology Transformation Oct 16, 2024
Consultant, Evidence Generation Hyderabad (Office) India Operations CTS Market Access Oct 16, 2024
Manager Economic Modelling Hyderabad (Office) India Operations CTS Market Access Oct 16, 2024
Senior Manager - Compliance and Risk Operations Hyderabad (Office) India Operations CTS Legal & Intellectual Property & Compl. Sep 18, 2024
Senior Expert Data Science Hyderabad (Office) India Operations Innovative Medicines Data and Digital Sep 18, 2024
Business Data Migration Expert – Customer master Hyderabad (Office) India Operations CTS BD&L & Strategic Planning Sep 18, 2024
Business Data Migration Expert – Finance Hyderabad (Office) India Operations CTS BD&L & Strategic Planning Oct 03, 2024
Business Data Migration Expert – Sales management Hyderabad (Office) India Operations CTS BD&L & Strategic Planning Sep 18, 2024
Business Data Migration Expert – Supply chain Hyderabad (Office) India Operations CTS BD&L & Strategic Planning Sep 19, 2024
Sr.Spec.DDIT ISC Gov Indep.Control Asses Hyderabad (Office) India Operations CTS Technology Transformation Sep 18, 2024
Business Data Migration Expert – Manufacturing Hyderabad (Office) India Operations CTS BD&L & Strategic Planning Sep 19, 2024
Senior Principal Product Operations Manager Hyderabad (Office) India Biomedical Research Innovative Medicines Research & Development Sep 19, 2024
Sr. Spec. DDIT IES DB & MW Services-IES- Cloud Platform Svcs Hyderabad (Office) India Operations CTS Technology Transformation Sep 19, 2024
BR Submission Management, Lead Hyderabad (Office) India Biomedical Research Research & Development Sep 19, 2024
BR Submission Management, Specialist Hyderabad (Office) India Biomedical Research Research & Development Sep 19, 2024
Analyst Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 20, 2024
Assoc. Dir. DDIT ISC Gov SOX IT Testing Hyderabad (Office) India Operations CTS Technology Transformation Sep 20, 2024
Sr. Spec. DDIT ISC Gov SOX IT Method Hyderabad (Office) India Operations CTS Technology Transformation Sep 20, 2024
Specialist - Quality Operations Hyderabad (Office) India Operations Innovative Medicines Quality Sep 23, 2024
Senior Manager ERP Assurance Hyderabad (Office) India Finance CTS Audit & Finance Sep 23, 2024
Manager, MarTech Hyderabad (Office) India Operations CTS Marketing Sep 24, 2024
Analyst- US Pharma Analytics Hyderabad (Office) India Operations CTS Marketing Sep 24, 2024
Associate Director Strategy and Operations Hyderabad (Office) India Development Innovative Medicines Research & Development Sep 24, 2024
Manager Martech Solutions Hyderabad (Office) India Operations CTS Marketing Sep 24, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia